Sotalol Hydrochloride Tablet
Product Images NDC 50268-725

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sotalol Hydrochloride (NDC 50268-725). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

80 (724 15 80mg)

Label for Sotalol Hydrochloride Tablets, USP 80 mg oral tablets. The package contains 50 tablets in unit dose (5 x 10). It includes storage instructions, manufacturer avPAK information, and a barcode. The label states Rx Only and provides temperature storage guidelines.*

FDA Label Image

120 (725 15 120mg)

Label for Sotalol Hydrochloride Tablets, USP 120 mg by AvPAK. This oral tablet packaging contains 50 tablets in a 5x10 unit dose format. The label includes storage instructions, dosage note, and barcode, emphasizing prescription-only status and manufacturer details in Pulaski, TN.*

FDA Label Image

Figure.jpg (Figure)

A line chart depicting the relationship between Age Factor and Age in months. The x-axis represents Age in months on a logarithmic scale from 0.1 to 50, and the y-axis represents Age Factor ranging from 0.0 to 1.0. The curve shows an increase in Age Factor with increasing age, approaching 1.0 for ages above 24 months.*

FDA Label Image

Figure2study1.jpg (Figure2study1)

A Kaplan-Meier survival curve chart comparing recurrence-free survival over time (days) for oral Sotalol at 80 mg, 120 mg, 160 mg doses versus placebo. The y-axis shows recurrence-free survival probability, and the x-axis shows time in days up to 360. The chart includes p-values from log-rank tests for each dose compared to placebo.*

FDA Label Image

Figure3study2.jpg (Figure3study2)

A Kaplan-Meier plot showing recurrence-free survival over time (days) comparing oral Sotalol Hydrochloride AF to placebo. The y-axis represents recurrence-free survival probability, and the x-axis shows time in days up to 180. The Sotalol Hydrochloride AF group maintains higher survival probability than placebo. The graph includes a p-value (0.002) from a log-rank test indicating statistical comparison.*

FDA Label Image

Structur.jpg (Structurefigure)

Chemical structure diagram of Sotalol Hydrochloride, showing its molecular arrangement including a phenyl group, sulfonamide, and hydrochloride components as depicted in the skeletal formula.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.